MBOT

MKT CAP:$100M

Microbot Medical Inc.

Market Cap

$100M

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$2.20+$0.09 (+4.27%)

Apr 21, 2026

Company Details

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, Ca...

CEO

Harel Gadot

IPO Date

Mar 25, 1992

Website

www.microbotmedical.com

Key Metrics TTM

Revenue

$0

— YoY

Net Income

-$13M

EPS (Diluted)

-$0.22

Free Cash Flow

-$13M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

Q1 2026

May 13, 2026

PENDING

FY 2025

Mar 26, 2026

$0EPS -$0.29

Q4 2025

Mar 26, 2026

$0EPS -$0.05

Q3 2025

Nov 12, 2025

$0EPS -$0.07

Q2 2025

Aug 12, 2025

$0EPS -$0.10

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$0	$0	-$3M
Q2 22	$0	$0	-$4M
Q3 22	$0	$0	-$3M
Q4 22	$0	$0	-$3M
Q1 23	$0	$0	-$3M
Q2 23	$0	$0	-$2M
Q3 23	$0	$0	-$3M
Q4 23	$0	-$35.0K	-$2M
Q1 24	$0	-$28.0K	-$2M
Q2 24	$0	$0	-$3M
Q3 24	$0	$0	-$3M
Q4 24	$0	-$26.0K	-$3M
Q1 25	$0	$0	-$3M
Q2 25	$0	-$12.0K	-$4M
Q3 25	$0	-$10.0K	-$4M
Q4 25	$0	-$10.0K	-$4M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$3M	-$3M
Q2 22	-$3M	-$3M
Q3 22	-$3M	-$3M
Q4 22	-$2M	-$2M
Q1 23	-$3M	-$3M
Q2 23	-$2M	-$2M
Q3 23	-$2M	-$2M
Q4 23	-$2M	-$2M
Q1 24	-$2M	-$2M
Q2 24	-$2M	-$2M
Q3 24	-$3M	-$3M
Q4 24	-$2M	-$2M
Q1 25	-$3M	-$3M
Q2 25	-$3M	-$3M
Q3 25	-$4M	-$4M
Q4 25	-$4M	-$4M

Capital Expenditures

Quarter	CapEx
Q1 22	$16.0K
Q2 22	$62.0K
Q3 22	$5.0K
Q4 22	$1.0K
Q1 23	$0
Q2 23	$10.0K
Q3 23	$28.0K
Q4 23	$5.0K
Q1 24	$14.0K
Q2 24	$4.0K
Q3 24	$0
Q4 24	$7.0K
Q1 25	$13.0K
Q2 25	$9.0K
Q3 25	$13.0K
Q4 25	$25.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	—	+32.8%
Q2 22	—	+43.9%
Q3 22	—	+36.1%
Q4 22	—	-22.1%
Q1 23	—	-8.1%
Q2 23	—	-34.8%
Q3 23	—	-26.8%
Q4 23	—	-32.6%
Q1 24	—	-18.3%
Q2 24	—	+8.0%
Q3 24	—	+29.7%
Q4 24	—	+65.9%
Q1 25	—	+26.7%
Q2 25	—	+48.3%
Q3 25	—	+17.0%
Q4 25	—	+20.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$429.0K	—
Q2 22	$432.0K	—
Q3 22	$461.0K	—
Q4 22	$430.0K	—
Q1 23	$412.0K	—
Q2 23	$349.0K	—
Q3 23	$336.0K	—
Q4 23	$297.0K	—
Q1 24	$453.0K	—
Q2 24	$331.0K	—
Q3 24	$283.0K	—
Q4 24	$282.0K	—
Q1 25	$256.0K	—
Q2 25	$237.0K	—
Q3 25	$328.0K	—
Q4 25	$236.0K	—

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 22	$2M	$1M	—	—
Q2 22	$2M	$1M	—	—
Q3 22	$2M	$2M	—	—
Q4 22	$2M	$1M	$224.0K	—
Q1 23	$2M	$1M	—	—
Q2 23	$1M	$959.0K	—	—
Q3 23	$2M	$932.0K	—	—
Q4 23	$1M	—	—	$938.0K
Q1 24	$1M	$1M	—	—
Q2 24	$1M	$1M	—	—
Q3 24	$2M	$1M	—	—
Q4 24	$2M	—	—	$1M
Q1 25	$1M	$2M	—	—
Q2 25	$2M	$2M	—	—
Q3 25	$1M	—	—	$3M
Q4 25	$2M	—	—	$3M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$10M	$2M	$12M
Q2 22	$7M	$2M	$9M
Q3 22	$4M	$2M	$6M
Q4 22	$3M	$6M	$8M
Q1 23	$2M	$3M	$5M
Q2 23	$6M	$4M	$10M
Q3 23	$1M	$7M	$8M
Q4 23	$2M	$4M	$6M
Q1 24	$1M	$5M	$6M
Q2 24	$2M	$4M	$6M
Q3 24	$479.0K	$4M	$4M
Q4 24	$3M	$2M	$5M
Q1 25	$3M	$27M	$30M
Q2 25	$4M	$29M	$33M
Q3 25	$7M	$73M	$80M
Q4 25	$4M	$75M	$79M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	7M	0.0%	0.0%
Q2 22	7M	0.0%	0.0%
Q3 22	7M	0.0%	0.0%
Q4 22	8M	+8.6%	+8.6%
Q1 23	8M	+3.8%	+12.7%
Q2 23	9M	+14.8%	+29.4%
Q3 23	12M	+27.3%	+64.7%
Q4 23	12M	+3.6%	+57.2%
Q1 24	14M	+15.9%	+75.4%
Q2 24	15M	+5.6%	+61.4%
Q3 24	16M	+10.9%	+40.7%
Q4 24	17M	+3.3%	+40.3%
Q1 25	17M	0.0%	+21.1%
Q2 25	36M	+114.4%	+145.8%
Q3 25	48M	+31.8%	+192.0%
Q4 25	67M	+39.6%	+294.6%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$0	17
Q2 22	$0	17
Q3 22	$0	17
Q4 22	$0	21
Q1 23	$0	21
Q2 23	$0	21
Q3 23	$0	21
Q4 23	$0	22
Q1 24	$0	22
Q2 24	$0	22
Q3 24	$0	22
Q4 24	$0	21
Q1 25	$0	21
Q2 25	$0	21
Q3 25	$0	21
Q4 25	$0	43

Revenue / Employee